Search Page

1

Cite

Share

Medicines, environment and clinical pharmacology.

Lapatto-Reiniluoto O, Siven M, Backman JT, Törrönen A. Lapatto-Reiniluoto O, et al. Among authors: siven m. Basic Clin Pharmacol Toxicol. 2022 Aug;131(2):149-152. doi: 10.1111/bcpt.13757. Epub 2022 Jun 5. Basic Clin Pharmacol Toxicol. 2022. PMID: 35603459

Cite

Share

2

Cite

Share

Regulation Awareness and Experience of Additional Monitoring among Healthcare Professionals in Finland.

Sandberg A, Ehlers P, Torvinen S, Sandberg H, Sivén M. Sandberg A, et al. Among authors: siven m. Healthcare (Basel). 2021 Nov 11;9(11):1540. doi: 10.3390/healthcare9111540. Healthcare (Basel). 2021. PMID: 34828586 Free PMC article.

Cite

Share

3

Cite

Share

Benefits and Prerequisites Associated with the Adoption of Oral 3D-Printed Medicines for Pediatric Patients: A Focus Group Study among Healthcare Professionals.

Rautamo M, Kvarnström K, Sivén M, Airaksinen M, Lahdenne P, Sandler N. Rautamo M, et al. Among authors: siven m. Pharmaceutics. 2020 Mar 5;12(3):229. doi: 10.3390/pharmaceutics12030229. Pharmaceutics. 2020. PMID: 32150899 Free PMC article.

Cite

Share

4

Cite

Share

A Focus Group Study about Oral Drug Administration Practices at Hospital Wards-Aspects to Consider in Drug Development of Age-Appropriate Formulations for Children.

Rautamo M, Kvarnström K, Sivén M, Airaksinen M, Lahdenne P, Sandler N. Rautamo M, et al. Among authors: siven m. Pharmaceutics. 2020 Jan 30;12(2):109. doi: 10.3390/pharmaceutics12020109. Pharmaceutics. 2020. PMID: 32019100 Free PMC article.

Cite

Share

5

Cite

Share

Under-Reporting of Adverse Drug Reactions in Finland and Healthcare Professionals' Perspectives on How to Improve Reporting.

Sandberg A, Salminen V, Heinonen S, Sivén M. Sandberg A, et al. Among authors: siven m. Healthcare (Basel). 2022 May 31;10(6):1015. doi: 10.3390/healthcare10061015. Healthcare (Basel). 2022. PMID: 35742066 Free PMC article.

Cite

Share

6

Cite

Share

Permeability and toxicity characteristics of L-cysteine and 2-methyl-thiazolidine-4-carboxylic acid in Caco-2 cells.

Kartal-Hodzic A, Marvola T, Schmitt M, Harju K, Peltoniemi M, Sivén M. Kartal-Hodzic A, et al. Among authors: siven m. Pharm Dev Technol. 2013 Nov-Dec;18(6):1288-93. doi: 10.3109/10837450.2012.659253. Epub 2012 Feb 22. Pharm Dev Technol. 2013. PMID: 22356486

Cite

Share

7

Cite

Share

Enantiospecific ketoprofen concentrations in plasma after oral and intramuscular administration in growing pigs.

Mustonen K, Niemi A, Raekallio M, Heinonen M, Peltoniemi OA, Palviainen M, Siven M, Peltoniemi M, Vainio O. Mustonen K, et al. Among authors: siven m. Acta Vet Scand. 2012 Sep 21;54(1):55. doi: 10.1186/1751-0147-54-55. Acta Vet Scand. 2012. PMID: 22998765 Free PMC article.

Cite

Share

8

Cite

Share

Early detection of ketoprofen-induced acute kidney injury in sheep as determined by evaluation of urinary enzyme activities.

Raekallio MR, Saario-Paunio EM, Rajamäki MM, Sankari SM, Palviainen MJ, Siven MS, Peltoniemi SM, Leinonen ME, Honkavaara JM, Vainio OM. Raekallio MR, et al. Among authors: siven ms. Am J Vet Res. 2010 Oct;71(10):1246-52. doi: 10.2460/ajvr.71.10.1246. Am J Vet Res. 2010. PMID: 20919914 Free article. Clinical Trial.

Cite

Share

9

Cite

Share

Compatibility of chewing gum excipients with the amino acid L-cysteine and stability of the active substance in directly compressed chewing gum formulation.

Kartal A, Björkqvist M, Lehto VP, Juppo AM, Marvola M, Sivén M. Kartal A, et al. Among authors: siven m. J Pharm Pharmacol. 2008 Sep;60(9):1131-8. doi: 10.1211/jpp.60.9.0003. J Pharm Pharmacol. 2008. PMID: 18718115

Cite

Share

10

Cite

Share

Challenge of paediatric compounding to solid dosage forms sachets and hard capsules - Finnish perspective.

Sivén M, Kovanen S, Siirola O, Hepojoki T, Isokirmo S, Laihanen N, Eränen T, Pellinen J, Juppo AM. Sivén M, et al. J Pharm Pharmacol. 2017 May;69(5):593-602. doi: 10.1111/jphp.12648. Epub 2016 Oct 5. J Pharm Pharmacol. 2017. PMID: 27704551

Cite

Share